reports
- GlobalData Healthcare Department
Otonomy Inc (OTIC) - Financial Analysis Review
Otonomy Inc (OTIC) - Financial Analysis Review Summary Otonomy Inc (Otonomy) that develops and commercializes treatments for unmet diseases in the field of otology. The company’s OTIPRIO is a formulation of ciprofloxacin that is useful for the treatment of patients with acute otitis externa. Its portfolio of pipeline products includes OTO-104, OTO-311 and OTO-4XX. GlobalData's Otonomy Inc (OTIC) - Financial Analysis Review provides a comprehensive insight into the company's history, busines...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.